BlueHalo's FE-1 Low-Cost Surface-To-Air Missile Fired For First Time
BlueHalo has, for the first time, launched its Freedom Eagle-1 (FE-1) missile, being developed for the U.S. Army's Next-Gen Counter-Uncrewed Aerial System (C-UAS) program. The new missile, intended to be relatively cheap to procure and able to be built rapidly in volume, is part of a new multi-pronged Army effort to better meet the proliferating drone threat head-on.
The successful live-fire demonstration of the FE-1 Controlled Test Vehicle (CTV) was only recently announced but took place from Jan. 16-18 this year, at Yuma Proving Ground, Arizona. It was conducted as part of the Next-Generation C-UAS Missile (NGCM) program, which aims to ramp up America's munitions industrial base to meet rapidly evolving aerial threats, specifically drones.
'In light of recent global events, including activities in Europe, the Red Sea, and Taiwan, we're taking a proactive stance — increasing internal investments to advance our FE-1 system and leaning in to meet the demand signal on an expedited timeline,' said Jonathan Moneymaker, BlueHalo chief executive officer.
The successful live fire demonstration of our Next-Gen #CUAS Missile, Freedom Eagle-1, shows how #TeamBlueHalo is addressing the critical need to meet rapidly evolving advanced aerial threats. We went from paper design to first flight in 107 days and we're thrilled to get one… pic.twitter.com/68QyfB27z1
— BlueHalo (@BlueHalo) March 13, 2025
The CTV live-fire demonstration at Yuma Proving Ground involved three missile test flights. 'In each of the three tests, FE-1 launched successfully and performed its flight as planned, affirming BlueHalo's commitment to a rapid development schedule. The team collected video, system, and sensor data logs, radar tracks, and RF diagnostics data from each flight test to evaluate the missile's guidance, navigation, and control systems and analyze aerodynamic models to drive down the significant technical risks associated with the program,' the company said.
The FE-1 launcher used for the Yuma tests was mounted on a flatbed trailer and was a simple cage-like construction, for a single missile, apparently intended only as a test rig. In the past, BlueHalo presented at least one concept for a four-round box-type launcher mounted on a pedestal atop a Stryker 8×8 wheeled armored fighting vehicle. This application, as well as a ship-based launcher (at around the 1:05 mark) are seen in the video below:
In keeping with its ambition of getting production-ready missiles into operational service sooner rather than later, the development of the FE-1 to date has been rapid.
In June of last year, BlueHalo announced that it had been selected as one of two vendors chosen to continue development of the NGCM by the U.S. Army Combat Capabilities Development Command Aviation & Missile Center (CCDC AvMC) Aviation & Missile Technology Consortium (AMTC).
Just two months later, the company announced the completion of multiple rounds of testing for the FE-1 low-cost effector, including the successful firing of its dual-thrust, solid-fuel rocket motor.
As of last December, BlueHalo had completed warhead detonation testing, which provided data on penetration depths, velocities, impacts, and panel fragmentation patterns.
Overall, it took BlueHalo 107 days to go from 'paper design to first flight,' the company says.
The next step is planned to include a customer live-fire demonstration in the third quarter of this year.
'It's clear that the new administration wants middle-tier acquisition going faster and fielding technology quicker,' explained Moneymaker. 'Additionally, Congress is supportive of additional effectors to get longer range, at higher altitudes, against a threat that is evolving faster than we can keep pace with current systems. We're moving at the speed necessary to meet the need, even if it requires our own internal funding to make it happen.'
The FE-1 is specifically designed to counter larger drones, in Group 3 and above. The U.S. military defines Group 3 drones as weighing between 55 and 1,320 pounds, being able to fly at altitudes between 3,500 and 18,000 feet, and having top speeds of between 100 and 250 knots.
To defeat threats such as these, the FE-1 is intended to have improved maneuverability, range, and rapid launch capabilities compared with current systems.
As well as drones, the FE-1 is intended to defeat various other 'larger air threats,' and to be integrated with existing infrastructure and command and control (C2) systems.
NGCM is one of at least four U.S. Army counter-drone-related competitions that are now underway, and which also include efforts to field a handheld C-UAS system for soldiers in combat, as well as a counter-drone radar.
As well as BlueHalo, Raytheon was selected as a vendor for NGCM development, for which it's preparing its Coyote.
Yet more contenders could still emerge, however.
'There are other companies out there that are working on interceptors for a counter-UAS application that might actually also have growth of potential to intercept … large caliber rockets, as well as potentially cruise missiles,' Brig. Gen. Frank Lozano, the Army's program executive officer for missiles and space, said in August of last year.
While Raytheon is well established in the field, BlueHalo is a relative upstart, but it is currently carving a niche as a specialist in innovative C-UAS solutions.
These also include directed-energy weapons, like the company's LOCUST laser weapon system — which you can read more about here. Meanwhile, the BlueHalo SkyView system provides for autonomous detection and precision tracking of small drones, using radio-frequency (RF) technology. Titan, another RF-based C-UAS solution from the same company, can detect, track, and force drones to safely land without disrupting nearby communications or electronics.
As we have discussed many times in the past, the threats posed by drones, including weaponized commercial types, are by no means new.
Nevertheless, the conflict in Ukraine has prompted a much wider rethink of C-UAS capabilities and how best to combat the various tiers of drones that might be operated by adversaries now and in the future. In particular, the requirement to be able to defend critical fixed infrastructure has been repeatedly demonstrated, most prominently by relentless Russian attacks on Ukraine using Shahed/Geran series long-range one-way attack drones. At the same time, there is a clear need to protect tanks and other armored vehicles against drones, especially highly maneuverable first-person view (FPV) kamikaze types.
A new air defense missile from a U.S. manufacturer is far from an everyday occurrence, making the emergence of the FE-1 notable in itself. At the same time, it is indicative of growing Army efforts to dramatically expand its air defense and counter-drone capabilities and capacity. Time will tell whether the Freedom Eagle-1 will also be a part of that future ecosystem.
Contact the author: thomas@thewarzone.com
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 days ago
- Yahoo
Why Recursion Pharmaceuticals (RXRX) Soared On Friday
We recently published a list of . In this article, we are going to take a look at where Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) stands against other Friday's best-performing stocks. Recursion Pharmaceuticals grew its share prices by 20.13 percent on Friday to close at $5.49 apiece following the unveiling of Boltz-2, touted as the next-generation AI model to predict binding affinity. According to Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX), the new model is powered by its NVIDIA supercomputer for its training and validation, and represents the next step beyond existing biomolecular structure prediction models like AlphaFold3 and its predecessor, Boltz-1. A pharmacist in a hospital pharmacy stands next to a row of various drug containers. 'Selecting the right molecules early is one of the most fundamental challenges in drug discovery, with implications for whether R&D programs succeed or fail,' said Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Chief Commercial Officer Najat Khan. 'By predicting both molecular structure and binding affinity simultaneously with unprecedented speed and scale, Boltz-2 gives R&D teams a powerful tool to triage more effectively and focus resources on the most promising compounds. Collaborations like this, bridging academic innovation and industry application, play an important role in advancing the field and, ultimately, improving how we develop and deliver medicines for patients,' she added. Overall, RXRX ranks 2nd on our list of Friday's best-performing stocks. While we acknowledge the potential of RXRX as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 days ago
- Yahoo
Why Recursion Pharmaceuticals (RXRX) Soared On Friday
We recently published a list of . In this article, we are going to take a look at where Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) stands against other Friday's best-performing stocks. Recursion Pharmaceuticals grew its share prices by 20.13 percent on Friday to close at $5.49 apiece following the unveiling of Boltz-2, touted as the next-generation AI model to predict binding affinity. According to Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX), the new model is powered by its NVIDIA supercomputer for its training and validation, and represents the next step beyond existing biomolecular structure prediction models like AlphaFold3 and its predecessor, Boltz-1. A pharmacist in a hospital pharmacy stands next to a row of various drug containers. 'Selecting the right molecules early is one of the most fundamental challenges in drug discovery, with implications for whether R&D programs succeed or fail,' said Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Chief Commercial Officer Najat Khan. 'By predicting both molecular structure and binding affinity simultaneously with unprecedented speed and scale, Boltz-2 gives R&D teams a powerful tool to triage more effectively and focus resources on the most promising compounds. Collaborations like this, bridging academic innovation and industry application, play an important role in advancing the field and, ultimately, improving how we develop and deliver medicines for patients,' she added. Overall, RXRX ranks 2nd on our list of Friday's best-performing stocks. While we acknowledge the potential of RXRX as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 days ago
- Yahoo
Crypto Currents: Strategy buys more bitcoin
As bitcoin, ethereum and other cryptocurrencies get increasing attention from investors, Wall Street and its traditional banks continue to adjust to the shift. Catch up on this week's top stories highlighting the intersection of these old guard and new school areas of finance with this recap compiled by The Fly. Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter STRATEGY BUYS MORE BITCOIN: Strategy (MSTR) announced updates on Monday with respect to its at-the-market offering programs and bitcoin holdings. The company purchased 705 bitcoin during the period of May 26 to June 1 at an aggregate purchase price of $75.1M. Strategy now holds 580,955 bitcoin. TRUMP MEDIA FILES REGISTRATION STATEMENT FOR BITCOIN ETF: On Thursday, Trump Media and Technology Group (DJT) announced the filing with the U.S. Securities and Exchange Commission of the initial registration statement on Form S-1 for the Truth Social Bitcoin ETF. The ETF will hold bitcoin directly and offer its shares to investors, aiming to reflect bitcoin's price performance. will act as the ETF's exclusive bitcoin custodian, prime execution agent and liquidity provider. The launch of the Truth Social Bitcoin ETF is pending effectiveness of the Registration Statement as well as approval of a Form 19b-4 filing with the SEC. Upon launch, the Shares will be listed on NYSE Arca. Yorkville America Digital acts as the sponsor of the ETF. Additionally on Thursday, Trump Media announced it has filed a registration statement on form S-3 with the U.S. Securities and Exchange Commission related to debt and equity subscription agreements recently entered into with approximately fifty investors that yielded approximately $2.3B in total proceeds. The proceeds will be used for the company's creation of a bitcoin treasury and for general corporate purposes. In accordance with registration obligations in the previously-disclosed agreements, the Registration Statement seeks to register for resale by the investors approximately 56M shares of equity and 29M shares underlying convertible notes. Additionally, having recently become form S-3 eligible, Trump Media is taking the customary step of including within the Registration Statement a universal shelf. CEO Devin Nunes said, 'These activities will provide the company with the capital, assets, independence, flexibility, and security we need to fulfill our goals of rapid expansion, guaranteeing a wide array of ways to access the capital markets when it's most advantageous to do so. We're systematically putting in place all the elements we need to grow the company according to our plans, acquire crown jewel assets, and draw more customers and users into the patriot economy.' MAWSON INFRASTRUCTURE APPOINTS INTERIM CEO: In a Thursday regulatory filing, Mawson Infrastructure Group (MIGI) reported it had provided Rahul Mewawalla with notice that termination of his employment as CEO and President of the company for 'Cause', based on conduct specified in the notice, will be considered at a future meeting of the company's Board of Directors, at which the Board will determine whether his conduct constitutes Cause sufficient to terminate Mewawalla in accordance with the terms of his employment agreement. Mewawalla's employment agreement with the company provides for a cure period, which will end on June 14. On June 2, the Board determined to place Mewawalla on administrative leave from his position as CEO and President and appointed Kaliste Saloom to serve as Interim CEO. Saloom has served as General Counsel and Corporate Secretary since July 1, 2024. HUT 8 INITIATED WITH BUY: On Thursday, Roth Capital initiated coverage of Hut 8 (HUT) with a Buy rating and $25 price target. Hut 8 is transforming into a power-first digital infrastructure platform, with 1.0GW energized, 2.6GW under exclusivity, and long-term growth visibility from bitcoin hosting and high-performance computing colocation, the analyst said. The firm added three HPC sites position the company to benefit from artificial intelligence demand, offering 60%-plus adjusted EBITDA margins. The combination of highly visible colocation agreements in bitcoin and HPC provides Hut 8 a strategic advantage, leading to margin expansion and re-rating potential with strategic execution, contended Roth. ANALYST CALLS GAMESTOP, STRATEGY VALUATION DISPARITY 'BAFFLING': On Thursday, Wedbush reiterated an Underperform rating on GameStop (GME) with a $13.50 price target after the company last week disclosed that it purchased 4,710 bitcoin, 'following the MicroStrategy playbook.' However, Strategy currently trades 1.75-times its bitcoin holdings, while GameStop trades at 2.4-times cash value, suggesting that investors value GameStop's entry into bitcoin at the same premium they assign to Strategy shares, but value GameStop's core operations at $8 per share, the analyst said. The firm added that while it is likely GameStop will convert more of its cash into bitcoin, the disparity in valuation between company and Strategy 'is baffling.' Both companies provide bitcoin investors the ability to use margin to invest in crypto, but GameStop's holdings 'are literally 1% as great as MSTR's,' according to Wedbush. The firm believes GameStop's entry into the trading card business has delivered 'modest success,' but it sees no potential for a rebound in the company's core business. OTHER CRYPTO NEWS: Bitcoin Depot (BTM) price target raised to $6 from $5 at Northland Riot Platforms (RIOT) hires Jonathan Gibbs as Chief Data Center Officer Trump's USD1 (JPM) to offer clients financing against crypto ETFs World Liberty Financial reportedly sends cease-and-desist over memecoin CRYPTO STOCK PLAYS: Publicly traded companies in the space include Bit Digital (BTBT), Coinbase (COIN), Core Scientific (CORZ), Greenidge Generation (GREE), Mara Holdings (MARA), Strategy, Riot Platforms and TeraWulf (WULF). PRICE ACTION: As of time of writing, bitcoin dropped roughly 1% this week to $104,449 in U.S. dollars, according to CoinDesk. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks recommended by analysts >> Read More on MSTR: Disclaimer & DisclosureReport an Issue Strategy Announces Underwriting Agreement with Barclays World Liberty Financial sends cease-and-desist over memecoin, Bloomberg reports GameStop and Strategy valuation disparity 'baffling,' says Wedbush Stablecoin Issuer Circle (CRCL) Soars 235% in Market Debut JPMorgan to offer clients financing against crypto ETFs, Bloomberg reports